IE33581L - Compositions comprising l-dopa - Google Patents
Compositions comprising l-dopaInfo
- Publication number
- IE33581L IE33581L IE691326A IE132669A IE33581L IE 33581 L IE33581 L IE 33581L IE 691326 A IE691326 A IE 691326A IE 132669 A IE132669 A IE 132669A IE 33581 L IE33581 L IE 33581L
- Authority
- IE
- Ireland
- Prior art keywords
- dopa
- compositions
- pharmaceutically acceptable
- acceptable salt
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Abstract
1,243,474. Compositions comprising dopa. MERCK & CO. Inc. 29 Sept., 1969 [1 Oct., 1968; 23 June, 1969], No. 47811/69. Heading A5B. Pharmaceutical compositions comprise L- dopa or a pharmaceutically acceptable salt thereof together with a α-hydrazino-α-R-3,4- dihydroxyphenyl-propionic acid or a pharmaceutically acceptable salt thereof, where R represents a hydrogen atom or a C 1 -C 4 alkyl radical. The hydrazine compound may be present as the D, L or racemic forms. A diluent, carrier, coating and/or excipient may be present.
[GB1243474A]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76432568A | 1968-10-01 | 1968-10-01 | |
| US83573069A | 1969-06-23 | 1969-06-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE33581L true IE33581L (en) | 1970-04-01 |
| IE33581B1 IE33581B1 (en) | 1974-08-21 |
Family
ID=27117439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1326/69A IE33581B1 (en) | 1968-10-01 | 1969-09-23 | Method of treatment and pharmaceutical preparation |
Country Status (10)
| Country | Link |
|---|---|
| BE (1) | BE739625A (en) |
| CA (1) | CA957945A (en) |
| CY (1) | CY648A (en) |
| DE (1) | DE1949376C3 (en) |
| ES (1) | ES372009A1 (en) |
| FR (1) | FR2019605B1 (en) |
| GB (1) | GB1243474A (en) |
| IE (1) | IE33581B1 (en) |
| IL (1) | IL33072A (en) |
| NL (1) | NL149372B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU464903B2 (en) * | 1970-11-12 | 1975-09-11 | Merck & Co., Inc | Treatment of hypertension |
| DE4101873C2 (en) * | 1991-01-23 | 1993-12-09 | Isis Pharma Gmbh | Orally administrable drug form for the treatment of central dopamine deficiency states |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3462536A (en) * | 1960-07-22 | 1969-08-19 | Merck & Co Inc | Method of inhibiting decarboxylase |
-
1969
- 1969-09-18 NL NL696914185A patent/NL149372B/en not_active IP Right Cessation
- 1969-09-23 IE IE1326/69A patent/IE33581B1/en unknown
- 1969-09-26 IL IL33072A patent/IL33072A/en unknown
- 1969-09-26 CA CA063,304A patent/CA957945A/en not_active Expired
- 1969-09-29 GB GB47811/69A patent/GB1243474A/en not_active Expired
- 1969-09-29 ES ES372009A patent/ES372009A1/en not_active Expired
- 1969-09-30 BE BE739625D patent/BE739625A/xx not_active IP Right Cessation
- 1969-09-30 DE DE1949376A patent/DE1949376C3/en not_active Expired
- 1969-10-01 FR FR696933459A patent/FR2019605B1/fr not_active Expired
-
1972
- 1972-07-04 CY CY64872A patent/CY648A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY648A (en) | 1972-07-04 |
| NL149372B (en) | 1976-05-17 |
| FR2019605A1 (en) | 1970-07-03 |
| IE33581B1 (en) | 1974-08-21 |
| FR2019605B1 (en) | 1973-06-08 |
| NL6914185A (en) | 1970-04-03 |
| DE1949376C3 (en) | 1978-08-31 |
| IL33072A0 (en) | 1969-11-30 |
| DE1949376A1 (en) | 1970-06-18 |
| CA957945A (en) | 1974-11-19 |
| IL33072A (en) | 1973-04-30 |
| BE739625A (en) | 1970-03-31 |
| GB1243474A (en) | 1971-08-18 |
| DE1949376B2 (en) | 1977-10-06 |
| ES372009A1 (en) | 1972-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE35209L (en) | 3, 4-dihydroisoquinoline derivatives. | |
| IE38979B1 (en) | Amides derived from quinoxaline | |
| ES456359A1 (en) | Fungicidal N-trichloroacetyl-N{40 -chlorobenzoylhydrazine derivatives | |
| IE33581L (en) | Compositions comprising l-dopa | |
| IE33371L (en) | Protozoacids; aminoguanidine derivatives | |
| IE35507B1 (en) | Anti-inflammatory preparations containing tetrahydrocarbazole derivatives | |
| IE34609B1 (en) | Antineoplastic therapeutic compositions | |
| IE34275L (en) | Alpha-hydrazino acids | |
| GB1336609A (en) | Antismoking preparation | |
| ES8304923A1 (en) | New peptide, process for preparation thereof and pharmaceutical composition containing it. | |
| GB1498083A (en) | Pharmaceutical preparations | |
| IE33346B1 (en) | Cyclohexa-1,4-diene-1-acetic acids | |
| GB1397675A (en) | Proline compounds | |
| CA789017A (en) | .delta.8,9-ergolene-8-carboxylic acid amide derivatives | |
| GB1501839A (en) | Pharmaceutical compositions for the inhibition of thrombocyte aggregation | |
| IE33519L (en) | Benzylhydrazides | |
| IE41495L (en) | N-methyl - 16, 17 - dihydr0-apovincamide | |
| ES363792A1 (en) | 2-Sulfanilamido-3-Halogeno-Pyridines | |
| GB1227936A (en) | ||
| IE33520L (en) | Benzylhydrazides | |
| GB1246225A (en) | Preparation of benzyl alcohol derivatives | |
| GB1288020A (en) | ||
| CA790063A (en) | .delta.8,9-ergolene-8-carboxylic acid amide derivatives | |
| GB1173985A (en) | Indole Derivatives | |
| AU451774B2 (en) | Amino derived from 3,4-ethylenedioxy- -phenylacetonitrile and its non-toxic acid addition salts |